drugset / Trial / NCT00780377
Intracoronary Bradykinin Mediated t-PA Release in Heart Transplant Recipients
Withdrawn
Vanderbilt University
NaSingle-groupOpen-labelBasic science
Summary
Heart transplant recipients do not have nerves to their hearts. This protocol tests the hypothesis that bradykinin mediated t-PA release in the coronary arteries will be reduced in heart transplant recipients compared to healthy subjects. This study will compare heart transplant recipients to healthy controls who are undergoing cardiac cath for standard of care purposes (separate protocol) and compare the coronary arteries to the forearm in transplant recipients (separate protocol) and healthy controls (separate protocol).
Timeline
- Start
- 2008-10
- Primary completion
- 2011-01
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bradykinin | Protein / enzyme biologic | 0 ug | Other |
| Subject | Bradykinin | Protein / enzyme biologic | 0.2 ug | Other |
| Subject | Bradykinin | Protein / enzyme biologic | 0.6 ug | Other |
| Subject | Bradykinin | Protein / enzyme biologic | 2 ug | Other |
Indications
No indication recorded.